×
Back to Agenda
Session 4: AI, Digitalisation and Innovation in Pharmacovigilance
Session Chair(s)
Maarten Lagendijk, MSc
Deputy EU QPPV, MSD, Netherlands
Sina Schader, DrMed
Head of QPPV Office and EU QPPV, AbbVie, Germany
QPPV Oversight and Training on AI
Speaker(s)
Health Authority Expectations on AI
Aise Sukran
Chair of PIC/S AI/ML Working Group | Senior GMP Inspector, Turkish Medicines and Medical Devices Agency (TITCK), Turkey
AI Best Practices: Big Pharma Examples
Anna Marques Banque, MHS
Lead QPPV Office Ops & Strategy, Deputy EU QPPV QPPV Office, PS&PV, Development, Novartis Farmaceutica S.A., Spain
QPPV Oversight and Training on AI
Fabian Heisig
Head Global Drug Safety & QPPV, Chief Medical Officer, Grünenthal GmbH, Germany
Have an account?